Literature DB >> 34183735

The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.

Kentaro Tojo1, Yoh Sugawara2, Yasufumi Oi3, Fumihiro Ogawa3, Takuma Higurashi4, Yukihiro Yoshimura5, Nobuyuki Miyata5, Hajime Hayami2, Yoshikazu Yamaguchi2, Yoko Ishikawa6, Ichiro Takeuchi3, Natsuo Tachikawa4, Takahisa Goto6.   

Abstract

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, total iron-binding capacity (TIBC), and transferrin saturation (TSAT) levels. Serum iron levels were significantly lower in patients with mild RF than in the non-RF group; however, there were no significant differences in iron levels between the non-RF and severe RF groups, depicting a U-shaped association between serum iron levels and disease severity. TIBC levels decreased significantly with increasing severity; consequently, TSAT was significantly higher in patients with severe RF than in other patients. Multivariate analysis including only patients with RF adjusted for age and sex demonstrated that higher serum iron and TSAT levels were independently associated with the development of severe RF, indicating that inadequate response to lower serum iron might be an exacerbating factor for COVID-19.

Entities:  

Year:  2021        PMID: 34183735     DOI: 10.1038/s41598-021-92921-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  7 in total

Review 1.  Iron and iron-related proteins in COVID-19.

Authors:  Erin Suriawinata; Kosha J Mehta
Journal:  Clin Exp Med       Date:  2022-07-18       Impact factor: 5.057

2.  Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection.

Authors:  Ana C Moreira; Maria Jose Teles; Tânia Silva; Clara M Bento; Inês Simões Alves; Luisa Pereira; João Tiago Guimarães; Graça Porto; Pedro Oliveira; Maria Salomé Gomes
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

3.  Serum iron indices in COVID-19-associated mucormycosis: A case-control study.

Authors:  Mohan Kumar H; Prashant Sharma; Shivaprakash M Rudramurthy; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashok Kumar Pannu; Reena Das; Naresh K Panda; Navneet Sharma; Arunaloke Chakrabarti; Ritesh Agarwal; Valliappan Muthu
Journal:  Mycoses       Date:  2021-11-16       Impact factor: 4.931

Review 4.  Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge.

Authors:  Bruna Teixeira da Costa; Glauber Rocha Lima Araújo; Ronaldo Teixeira da Silva Júnior; Luana Kauany de Sá Santos; Vinícius Lima de Souza Gonçalves; Daniel Bastos Alves Lima; Beatriz Rocha Cuzzuol; Jonathan Santos Apolonio; Lorena Sousa de Carvalho; Hanna Santos Marques; Camilo Santana Silva; Isadora de Souza Barcelos; Márcio Vasconcelos Oliveira; Fabrício Freire de Melo
Journal:  World J Crit Care Med       Date:  2022-07-09

5.  Circulating trace elements status in COVID-19 disease: A meta-analysis.

Authors:  Yunhui Li; Weihe Luo; Bin Liang
Journal:  Front Nutr       Date:  2022-08-12

Review 6.  The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-Analysis.

Authors:  Shuya Zhou; Huihui Li; Shiru Li
Journal:  Nutrients       Date:  2022-08-19       Impact factor: 6.706

7.  Iron status and the risk of sepsis and severe COVID-19: a two-sample Mendelian randomization study.

Authors:  Randi Marie Mohus; Helene Flatby; Kristin V Liyanarachi; Andrew T DeWan; Erik Solligård; Jan Kristian Damås; Bjørn Olav Åsvold; Lise T Gustad; Tormod Rogne
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.